Back to search

Article

Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>

2021-10-05

Abstract excerpt

<h4>SUMMARY</h4> The COVID-19 pandemic persists as a global health crisis for which curative treatment has been elusive. Development of effective and safe anti-SARS-CoV-2 therapies remains an urgent need. SARS-CoV-2 entry into cells requires specific host proteases including TMPRSS2 and Cathepsin L (Ctsl) 1–3 , but there has been no reported success in inhibiting host proteases for treatment of SARS-CoV-2 pathog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ac46e820-ac88-56f7-b55a-a30cad25a269
DOI
10.1101/2021.10.03.462915
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>DOI 10.1101/2021.10.03.462915
Select a neighboring publication to make it the new centre.